Skip to content

Comparision of Use of Anaesthetic Gases Versus Propofol infusion On Occurrence of Nausea and Vomiting after Surgery

Comparative Evaluation Of Inhalational Anaesthetic Technique Versus Propofol Infusion On The Incidence Of Post Operative Nausea and Vomiting In Patients Undergoing Laparoscopic Gynecological Surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038767
Enrollment
60
Registered
2021-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: Post-Operative Nausea and Vomiting Prevention: After Completion of Surgery, patients will be followed upto 24 hours post operatively at interval of 0, 2, 6, 12, 24 hours and incidence o

Sponsors

Vardhman Mahavir Medical College And Safdarjung Hospital New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Female Patients aged 18-65 years with ASA class I and II undergoing gynecological laparoscopic surgery

Exclusion criteria

Exclusion criteria: Female patient with history of post operative nausea and vomiting, motion sickness, smoker, pregnant and lactating mother, women in their perimenstrual period and history of hypersensitivity to any of the study drug.

Design outcomes

Primary

MeasureTime frame
Post- Operative Nausea And VomitingTimepoint: Post- Operatively upto 24 hours

Secondary

MeasureTime frame
Grading of PONV, Post-operative pain and hemodynamic stability of patients.Timepoint: post-operatively upto 24hours

Countries

India

Contacts

Public ContactDr Dharam Singh Meena

Vardhman Mahavir Medical College & Safdarjung Hospital

dharams_meena@yahoo.com9910277131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026